37. Deputy David Stanton asked the Minister for Health the State's position with respect to the EU revision of pharmaceutical legislation ahead of EU Parliamentary Committee votes expected in March 2024; if he supports proposals to reduce regulatory data protection for manufacturers; the impact that such a reduction will have on patients; and if he will make a statement on the matter. [9568/24]

Summary

37. Deputy David Stanton asked the Minister for Health the State's position with respect to the EU revision of pharmaceutical legislation ahead of EU Parliamentary Committee votes expected in March 2024; if he supports proposals to reduce regulatory data protection for manufacturers; the impact that such a reduction will have on patients; and if he will make a statement on the matter. [9568/24]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 29 February 2024

   Medicinal Products

   37. Deputy David Stanton asked the Minister for Health the State's position with respect to the EU revision of pharmaceutical legislation ahead of EU Parliamentary Committee votes expected in March 2024; if he supports proposals to reduce regulatory data protection for manufacturers; the impact that such a reduction will have on patients; and if he will make a statement on the matter. [9568/24]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 29 February 2024

  ViewDownloadOpen at official source

Sponsors

• Stanton, David. · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.